Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hip pain study tracks patients for 7 years to see how symptoms change

NCT ID NCT03490071

Knowledge-focused Sponsor: Lund University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study followed 58 people aged 18-55 with long-term hip and groin pain for 3 and 7 years after their first visit to a specialist. Researchers used questionnaires to measure symptoms, daily function, sports ability, and quality of life. The goal was to understand how these patients fare over time, without testing any new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

58 people

The number who actually took part.

Started

Jan 2018

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients will be recruited from the Department of Orthopedics, Skåne University Hospital, Sweden.

Ages

18 to 55 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

At baseline, the following inclusion and exclusion criteria were used: Inclusion criteria: * Unilateral or bilateral hip/groin pain \>3 months * Age 18-55 years * No previous hip surgery Exclusion criteria: * Hip pathology (i.e., Perthes' disease) * Verified moderate or severe osteoarthritis (OA) (Tönnis grade \>1) * Palpable hernia * Low-back pain with a positive Lasègue test * MRI-verified lower back/spine pathology (i.e., spinal stenosis, disc herniation) * Other musculoskeletal co-morbidities overriding the hip-related symptoms and dysfunction * Co-morbidities excluding physical activity and training * Psycho-social disorders * Drug abuse * Not understanding the language of interest.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip pain chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip pain chronic

Contacts and locations

Locations

  • Department of Health Sciences, Lund University

    Lund, 22100, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.